Cohort (LON:CHRT – Get Free Report)‘s stock had its “buy” rating reissued by investment analysts at Shore Capital in a research note issued on Wednesday,Digital Look reports. They presently have a GBX 1,630 ($21.82) target price on the stock. Shore Capital’s price target indicates a potential downside of 6.45% from the company’s current price.
Cohort Stock Performance
Shares of CHRT stock opened at GBX 1,742.40 ($23.33) on Wednesday. The company has a fifty day moving average price of GBX 1,517.33 and a two-hundred day moving average price of GBX 1,295.75. Cohort has a one year low of GBX 760.50 ($10.18) and a one year high of GBX 1,796 ($24.05). The stock has a market cap of £790.88 million, a P/E ratio of 46.02 and a beta of 0.56. The company has a debt-to-equity ratio of 37.28, a current ratio of 1.55 and a quick ratio of 0.93.
Insider Transactions at Cohort
In related news, insider Simon Walther sold 350 shares of Cohort stock in a transaction dated Wednesday, April 23rd. The stock was sold at an average price of GBX 1,275 ($17.07), for a total transaction of £4,462.50 ($5,974.70). Company insiders own 39.22% of the company’s stock.
About Cohort
Cohort plc is the parent company of seven innovative, agile and responsive businesses based in the UK, Australia, Germany and Portugal, providing a wide range of services and products for domestic and export customers in defence and related markets.
The Group is split into two segments:
Communications and Intelligence
– EID designs and manufactures advanced communications systems for naval and military customers.
Recommended Stories
- Five stocks we like better than Cohort
- Short Selling – The Pros and Cons
- JPMorgan Q2 Results Affirm Dividend, Buybacks, & Growth
- Health Care Stocks Explained: Why You Might Want to Invest
- Goldman Spotlights These 3 Stocks in Its Bullish S&P 500 Outlook
- Insider Trades May Not Tell You What You Think
- Fastenal Surges After Earnings Beat, Tariff Risks Loom
Receive News & Ratings for Cohort Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cohort and related companies with MarketBeat.com's FREE daily email newsletter.